How Hyaluronic Acid-Chitosan Nanoparticles Enter Eye Cells
Author Information
Author(s): Laura Contreras-Ruiz, María de la Fuente, Jenny E. Párraga, Antonio López-García, Itziar Fernández, Begoña Seijo, Alejandro Sánchez, Margarita Calonge, Yolanda Diebold
Primary Institution: Ocular Surface Group-IOBA, University of Valladolid, Valladolid, Spain
Hypothesis
The study aims to determine the internalization pathway used by ocular surface cell lines to take up hyaluronic acid-chitosan oligomer-based nanoparticles.
Conclusion
Hyaluronic acid-chitosan nanoparticles are effectively internalized by ocular surface cells through an active transport mechanism without compromising cell viability.
Supporting Evidence
- HA-CSO nanoparticles were internalized by corneal and conjunctival cells through an active transport mechanism.
- The uptake was significantly reduced by blocking hyaluronan receptors.
- Most of the nanoparticles were metabolized within 48 hours without affecting cell viability.
Takeaway
Scientists created tiny particles to help deliver medicine to the eye, and they found that these particles can get into eye cells safely and effectively.
Methodology
The study involved creating nanoparticles and exposing human epithelial cell lines to them, followed by fluorescence microscopy and fluorometry to assess uptake.
Limitations
The study does not explore all potential uptake mechanisms and focuses primarily on two cell lines.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website